News
More than a million people are infected every year with the Human Immunodeficiency Virus (HIV), despite decades of work ...
Two clinical trials show the injection is nearly 100% effective at stopping new HIV infections. The vaccine is marketed under ...
The FDA has approved Yeztugo, the first long-acting injectable PrEP shot, which could significantly impact HIV prevention ...
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
ABC News contributor Dr. Alok Patel and Ian Haddock, founder of the Normal Anomaly Initiative, discuss the FDA’s decision to ...
Men, women, gay, straight – it really just kinds of expands the opportunity for prevention’ Source: Twice-a-year shot to prevent HIV could stop transmission — if people can get it – Zimbabwe News Now ...
The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...
The U.S. Food and Drug Administration has approved a groundbreaking new HIV prevention drug that offers near-total protection ...
A major win in the fight against HIV. The Food and Drug Administration has approved a new shot that cuts down on the risk of contracting the deadly virus.
4h
Zacks Investment Research on MSNFDA Approves Gilead's Twice-Yearly Shot for HIV PreventionGilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results